Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma that affects B-cells, leading to rapid growth of tumors in lymph nodes and other organs.
Diffuse Large B-cell Lymphoma: Rituximab and Golcadomide Study
We are testing a new combination treatment for older frail patients with Diffuse Large B-cell non-Hodgkin Lymphoma. This study aims to see if it can improve outcomes without traditional chemotherapy.
>2 yearsEfficacy phase (II)No PlaceboInvestigational MedicinesOralInjectionHematologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have a diagnosis of DLBCL (Diffuse Large B-Cell Lymphoma)?
- Have you had any other active cancers in the last 5 years, except for certain skin cancers?
- Are you currently taking any medications for hepatitis B or C, or do you have active hepatitis?
- Do you have any significant heart problems or other serious health issues that affect your ability to participate?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Golcadomide
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Azienda Ospedaliero-Universitaria Ss.Antonio E Biagio E C.Arrigo Alessandria
SCDU Ematologia
Alessandria, Italy
Azienda Ospedaliero Universitaria Delle Marche
Clinica di Ematologia
Ancona, Italy
AORN San Giuseppe Moscati Avellino
S.C. Ematologia e Trapianto emopoietico
Avellino, Italy
Sponsor: Fondazione Italiana Linfomi Ets
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.